THE KMH
RESEARCH CENTRE
PROGRESS THROUGH RESEARCH
The KMH team is comprised of accomplished
and innovative professionals dedicated to
advancing health care through ongoing research
and development. KMH operates a major R & D
facility in Ontario, Canada with a sound
reputation for excellence. Our scientists are
catalysts for discovery and regularly conduct
clinical trials.
Major R&D Facility: Mississauga
Nuclear Medicine Division
Principle Research Investigator: Kathy Yip, M.D., F.R.C.P. (C)
R&D Focus:
Evaluation of myocardial perfusion imaging for enhanced diagnostic capability and
cost effectiveness;
Clinical evaluation of early detection of malignant breast lesions
in high risk patients using new nuclear medicine technology with
correlation to MRI and conventional breast investigational techniques;
Evaluation of cardiac viability using FDG as an adjunct to determine
the necessity of implantable defibrillator in patients with intermediate left ventricular dysfunction;
Application of Positron Emission Tomography in Oncology.
Cardiology DivisionCardiology DivisionCardiology Division
Principle Research Investigator:Arvinder Grover,
M.D., F.R.C.P. (C)
R&D Focus:
Phase III and IV Clinical trials for management of hypercholesterolemia
focusing on concomitant coronary artery disease and ethnicity.
Information Technology Division
Principle Research Investigator: Neena Kanwar, B.Sc., MRT (NM)
R&D Focus:
Development and evaluation of electronic medical record software and diagnostic
services management software.
Research
